Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Gliosarcoma 3Glioblastoma 3Brain Neoplasms 3Astrocytoma 3Oligodendroglioma 2Glioma 2Central Nervous System Neoplasms 2Medulloblastoma 1Familial ependymoma 1Ependymoma 1Drug-Related Side Effects and Adverse Reactions 1

Interventions

apatinib 4Ifosfamide 2Filgrastim 2Etoposide 2selinexor 1glucarpidase 1camrelizumab 1Vincristine 1Radiotherapy 1Procarbazine 1Pharmaceutical Preparations 1Methotrexate 1Lomustine 1Imatinib Mesylate 1Genetic Therapy 1Fibroblast Growth Factor 7 1Drug Combinations 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × Genetic Therapy × Sarcoma × Clear all
NCT00005796 2015-03-25

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Indiana University

Phase 1 Completed
10 enrolled
CNSSarcoma

Familial ependymoma, Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡